An Evaluation of Meprobamate in the Management of Selected Dermatoses
- 1 April 1958
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 77 (4) , 406-411
- https://doi.org/10.1001/archderm.1958.01560040030005
Abstract
Introduction When the ataractic (tranquilizing) drugs were developed, they were alleged to offer alleviation of anxiety, emotional stress, and nervous tension, which so often play an important role in the production or perpetuation of various dermatoses. These drugs were claimed to be safe and free of side-effects, and it was claimed that they did not produce habituation. These factors stimulated us to evaluate the effects of meprobamate* in selected dermatoses, and the results of its administration in 260 patients are reported. Drug Meprobamate is a simple aliphatic compound and is the decarbonic ester of 3-0--toloxy-1,2-propanediol (mephenesin). Meprobamate produces muscle relaxation, and animal experiments have demonstrated it to have anticonvulsant action as well as the ability to tame disturbed animals. Only in excessive doses can the cerebral cortex be depressed.1,2 Review of Literature Enthusiasm for the drug following clinical studies has varied. Selling3 found itKeywords
This publication has 0 references indexed in Scilit: